Axis-Shield prepares US maiden product launch after EU release
This article was originally published in Clinica
The imminent European launch of Afinion - Axis-Shield's new doctor's office diagnostic - represents more than just another product introduction. The Anglo-Norwegian firm plans to use it as a gateway to the lucrative US point-of-care (POC) market, a move analysts believe could spur the company to profitability by the end of next year, reports Daniel Barry
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.